Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example
Assessment of COPD Therapy From the Physicians Perspective Using Tiotropium as an Example
1 other identifier
observational
N/A
1 country
352
Brief Summary
Documentation of successful therapy with tiotropium (Spiriva Respimat; Spiriva (tiotropium 18 mcg capsules)) in COPD patients requiring long-acting bronchodilators: description of the most important outcome parameters according to the physicians assessment to determine the success of therapy. Such data are not yet available. Also collection of physicians assessments and patients assessments of efficacy and tolerability of Spiriva Respimat, Spiriva (tiotropium 18 mcg capsules).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
352 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2009
CompletedFirst Posted
Study publicly available on registry
December 21, 2009
CompletedStudy Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedResults Posted
Study results publicly available
March 22, 2012
CompletedMarch 27, 2014
February 1, 2014
7 months
December 18, 2009
February 15, 2012
February 27, 2014
Conditions
Outcome Measures
Primary Outcomes (5)
Success of Treatment With Tiotropium According to Physician's Assessment
Evaluation of important outcome parameters (pulmonary function, dyspnoe, health-related quality of life, exercise capacity, prevention of exacerbations) which were used for the physician´s decision to assess the treatment as successful
6 - 12 weeks
Assessment of Efficacy According to Physician
Physician's assessment of efficacy within categories (positive/ negative), concurrent proportion of positive efficacy assessments by both physician and patient was determined
6 - 12 weeks
Assessment of Tolerability According to Physician
Physician's assessment of tolerability (positve/ negative), concurrent proportion of positive efficacy assessments by both physician and patient was determined
6 - 12 weeks
Assessment of Efficacy According to Patient
patient-reported assessment within categories (Very good, good, satisfactory, less satisfactory, unsatisfactory, missing)
6 - 12 weeks
Assessment of Tolerability According to Patient
Patient-reported assessment within categories (Very good, good, satisfactory, less satisfactory, unsatisfactory, missing)
6 - 12 weeks
Secondary Outcomes (2)
Physician's Global Evaluation at Visit 1
0 weeks
Physician's Global Evaluation at Visit 2
after 6 - 12 weeks
Eligibility Criteria
Patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boehringer Ingelheimlead
- Pfizercollaborator
Study Sites (352)
Boehringer Ingelheim Investigational Site 1
Ahrensburg, Germany
Boehringer Ingelheim Investigational Site 2
Amberg, Germany
Boehringer Ingelheim Investigational Site 3
Arnstadt, Germany
Boehringer Ingelheim Investigational Site 4
Auerbach, Germany
Boehringer Ingelheim Investigational Site 10
Augsburg, Germany
Boehringer Ingelheim Investigational Site 5
Augsburg, Germany
Boehringer Ingelheim Investigational Site 6
Augsburg, Germany
Boehringer Ingelheim Investigational Site 7
Augsburg, Germany
Boehringer Ingelheim Investigational Site 8
Augsburg, Germany
Boehringer Ingelheim Investigational Site 9
Augsburg, Germany
Boehringer Ingelheim Investigational Site 11
Backnang, Germany
Boehringer Ingelheim Investigational Site 12
Bad Doberan, Germany
Boehringer Ingelheim Investigational Site 13
Bad Kissingen, Germany
Boehringer Ingelheim Investigational Site 15
Bad Kötzting, Germany
Boehringer Ingelheim Investigational Site 16
Bad Kötzting, Germany
Boehringer Ingelheim Investigational Site 14
Bad Krozingen, Germany
Boehringer Ingelheim Investigational Site 17
Bad Lippspringe, Germany
Boehringer Ingelheim Investigational Site 18
Bad Neuenahr-Ahrweiler, Germany
Boehringer Ingelheim Investigational Site 19
Bad Neustadt an der Saale, Germany
Boehringer Ingelheim Investigational Site 20
Bad Reichenhall, Germany
Boehringer Ingelheim Investigational Site 21
Bad Reichenhall, Germany
Boehringer Ingelheim Investigational Site 22
Bad Sachsa, Germany
Boehringer Ingelheim Investigational Site 23
Bad Wörishofen, Germany
Boehringer Ingelheim Investigational Site 24
Baden-Baden, Germany
Boehringer Ingelheim Investigational Site 25
Ballenstedt, Germany
Boehringer Ingelheim Investigational Site 26
Bamberg, Germany
Boehringer Ingelheim Investigational Site 27
Bautzen, Germany
Boehringer Ingelheim Investigational Site 28
Beelitz, Germany
Boehringer Ingelheim Investigational Site 29
Bensheim, Germany
Boehringer Ingelheim Investigational Site 30
Bergisch Gladbach, Germany
Boehringer Ingelheim Investigational Site 31
Berlin, Germany
Boehringer Ingelheim Investigational Site 32
Berlin, Germany
Boehringer Ingelheim Investigational Site 33
Berlin, Germany
Boehringer Ingelheim Investigational Site 34
Berlin, Germany
Boehringer Ingelheim Investigational Site 35
Berlin, Germany
Boehringer Ingelheim Investigational Site 36
Berlin, Germany
Boehringer Ingelheim Investigational Site 37
Berlin, Germany
Boehringer Ingelheim Investigational Site 38
Berlin, Germany
Boehringer Ingelheim Investigational Site 39
Berlin, Germany
Boehringer Ingelheim Investigational Site 40
Berlin, Germany
Boehringer Ingelheim Investigational Site 41
Berlin, Germany
Boehringer Ingelheim Investigational Site 42
Berlin, Germany
Boehringer Ingelheim Investigational Site 43
Berlin, Germany
Boehringer Ingelheim Investigational Site 44
Berlin, Germany
Boehringer Ingelheim Investigational Site 45
Berlin, Germany
Boehringer Ingelheim Investigational Site 46
Berlin, Germany
Boehringer Ingelheim Investigational Site 47
Berlin, Germany
Boehringer Ingelheim Investigational Site 48
Berlin, Germany
Boehringer Ingelheim Investigational Site 49
Berlin, Germany
Boehringer Ingelheim Investigational Site 50
Berlin, Germany
Boehringer Ingelheim Investigational Site 51
Berlin, Germany
Boehringer Ingelheim Investigational Site 52
Berlin, Germany
Boehringer Ingelheim Investigational Site 53
Bernau, Germany
Boehringer Ingelheim Investigational Site 54
Bitterfeld-Wolfen, Germany
Boehringer Ingelheim Investigational Site 55
Bochum, Germany
Boehringer Ingelheim Investigational Site 56
Bochum, Germany
Boehringer Ingelheim Investigational Site 57
Bonn, Germany
Boehringer Ingelheim Investigational Site 58
Bonn, Germany
Boehringer Ingelheim Investigational Site 59
Bonn, Germany
Boehringer Ingelheim Investigational Site 60
Bonn, Germany
Boehringer Ingelheim Investigational Site 61
Bottrop, Germany
Boehringer Ingelheim Investigational Site 62
Braunschweig, Germany
Boehringer Ingelheim Investigational Site 63
Braunschweig, Germany
Boehringer Ingelheim Investigational Site 64
Bremen, Germany
Boehringer Ingelheim Investigational Site 65
Bremen, Germany
Boehringer Ingelheim Investigational Site 66
Bremen, Germany
Boehringer Ingelheim Investigational Site 67
Bremen, Germany
Boehringer Ingelheim Investigational Site 68
Bremerhaven, Germany
Boehringer Ingelheim Investigational Site 69
Bremerhaven, Germany
Boehringer Ingelheim Investigational Site 70
Bruchsal, Germany
Boehringer Ingelheim Investigational Site 71
Buchholz, Germany
Boehringer Ingelheim Investigational Site 72
Castrop-Rauxel, Germany
Boehringer Ingelheim Investigational Site 73
Celle, Germany
Boehringer Ingelheim Investigational Site 74
Celle, Germany
Boehringer Ingelheim Investigational Site 75
Chemnitz, Germany
Boehringer Ingelheim Investigational Site 76
Coburg, Germany
Boehringer Ingelheim Investigational Site 77
Coburg, Germany
Boehringer Ingelheim Investigational Site 200
Cologne, Germany
Boehringer Ingelheim Investigational Site 201
Cologne, Germany
Boehringer Ingelheim Investigational Site 202
Cologne, Germany
Boehringer Ingelheim Investigational Site 78
Cottbus, Germany
Boehringer Ingelheim Investigational Site 79
Cottbus, Germany
Boehringer Ingelheim Investigational Site 80
Dachau, Germany
Boehringer Ingelheim Investigational Site 81
Darmstadt, Germany
Boehringer Ingelheim Investigational Site 82
Deggendorf, Germany
Boehringer Ingelheim Investigational Site 83
Delitzsch, Germany
Boehringer Ingelheim Investigational Site 84
Dessau, Germany
Boehringer Ingelheim Investigational Site 85
Dillingen, Germany
Boehringer Ingelheim Investigational Site 86
Dillingen, Germany
Boehringer Ingelheim Investigational Site 87
Donaueschingen, Germany
Boehringer Ingelheim Investigational Site 88
Dorsten, Germany
Boehringer Ingelheim Investigational Site 89
Dortmund, Germany
Boehringer Ingelheim Investigational Site 90
Dresden, Germany
Boehringer Ingelheim Investigational Site 91
Dresden, Germany
Boehringer Ingelheim Investigational Site 92
Dresden, Germany
Boehringer Ingelheim Investigational Site 93
Dresden, Germany
Boehringer Ingelheim Investigational Site 94
Dresden, Germany
Boehringer Ingelheim Investigational Site 95
Dresden, Germany
Boehringer Ingelheim Investigational Site 96
Dresden, Germany
Boehringer Ingelheim Investigational Site 97
Düren, Germany
Boehringer Ingelheim Investigational Site 98
Düren, Germany
Boehringer Ingelheim Investigational Site 100
Düsseldorf, Germany
Boehringer Ingelheim Investigational Site 101
Düsseldorf, Germany
Boehringer Ingelheim Investigational Site 102
Düsseldorf, Germany
Boehringer Ingelheim Investigational Site 99
Düsseldorf, Germany
Boehringer Ingelheim Investigational Site 103
Eichstätt, Germany
Boehringer Ingelheim Investigational Site 104
Emden, Germany
Boehringer Ingelheim Investigational Site 105
Erbach im Odenwald, Germany
Boehringer Ingelheim Investigational Site 106
Erfurt, Germany
Boehringer Ingelheim Investigational Site 107
Erfurt, Germany
Boehringer Ingelheim Investigational Site 108
Erfurt, Germany
Boehringer Ingelheim Investigational Site 109
Erlangen, Germany
Boehringer Ingelheim Investigational Site 110
Eschwege, Germany
Boehringer Ingelheim Investigational Site 111
Esslingen am Neckar, Germany
Boehringer Ingelheim Investigational Site 112
Esslingen am Neckar, Germany
Boehringer Ingelheim Investigational Site 113
Euskirchen, Germany
Boehringer Ingelheim Investigational Site 114
Fellbach, Germany
Boehringer Ingelheim Investigational Site 115
Flensburg, Germany
Boehringer Ingelheim Investigational Site 116
Forchheim, Germany
Boehringer Ingelheim Investigational Site 123
Föhren, Germany
Boehringer Ingelheim Investigational Site 117
Frankenthal, Germany
Boehringer Ingelheim Investigational Site 118
Frankfurt, Germany
Boehringer Ingelheim Investigational Site 119
Frankfurt, Germany
Boehringer Ingelheim Investigational Site 120
Frankfurt, Germany
Boehringer Ingelheim Investigational Site 121
Frankfurt, Germany
Boehringer Ingelheim Investigational Site 122
Freising, Germany
Boehringer Ingelheim Investigational Site 124
Fürstenfeldbruck, Germany
Boehringer Ingelheim Investigational Site 125
Fürth, Germany
Boehringer Ingelheim Investigational Site 126
Fürth, Germany
Boehringer Ingelheim Investigational Site 127
Ganderkesee, Germany
Boehringer Ingelheim Investigational Site 128
Gauting, Germany
Boehringer Ingelheim Investigational Site 129
Geilenkirchen, Germany
Boehringer Ingelheim Investigational Site 130
Gelsenkirchen, Germany
Boehringer Ingelheim Investigational Site 131
Gelsenkirchen, Germany
Boehringer Ingelheim Investigational Site 132
Gera, Germany
Boehringer Ingelheim Investigational Site 133
Germering, Germany
Boehringer Ingelheim Investigational Site 134
Giessen, Germany
Boehringer Ingelheim Investigational Site 135
Giessen, Germany
Boehringer Ingelheim Investigational Site 140
Göppingen, Germany
Boehringer Ingelheim Investigational Site 141
Göttingen, Germany
Boehringer Ingelheim Investigational Site 142
Göttingen, Germany
Boehringer Ingelheim Investigational Site 143
Göttingen, Germany
Boehringer Ingelheim Investigational Site 136
Greiz, Germany
Boehringer Ingelheim Investigational Site 137
Grevesmühlen, Germany
Boehringer Ingelheim Investigational Site 138
Großenhain, Germany
Boehringer Ingelheim Investigational Site 139
Gummersbach, Germany
Boehringer Ingelheim Investigational Site 144
Günzburg, Germany
Boehringer Ingelheim Investigational Site 145
Gütersloh, Germany
Boehringer Ingelheim Investigational Site 146
Gütersloh, Germany
Boehringer Ingelheim Investigational Site 147
Gütersloh, Germany
Boehringer Ingelheim Investigational Site 148
Hagen, Germany
Boehringer Ingelheim Investigational Site 149
Halberstadt, Germany
Boehringer Ingelheim Investigational Site 150
Halle, Germany
Boehringer Ingelheim Investigational Site 151
Halle, Germany
Boehringer Ingelheim Investigational Site 152
Hamburg, Germany
Boehringer Ingelheim Investigational Site 153
Hamburg, Germany
Boehringer Ingelheim Investigational Site 154
Hamburg, Germany
Boehringer Ingelheim Investigational Site 155
Hamburg, Germany
Boehringer Ingelheim Investigational Site 156
Hamburg, Germany
Boehringer Ingelheim Investigational Site 157
Hamburg, Germany
Boehringer Ingelheim Investigational Site 158
Hamburg, Germany
Boehringer Ingelheim Investigational Site 159
Hamburg, Germany
Boehringer Ingelheim Investigational Site 160
Hamburg, Germany
Boehringer Ingelheim Investigational Site 161
Hamburg, Germany
Boehringer Ingelheim Investigational Site 162
Hamburg, Germany
Boehringer Ingelheim Investigational Site 163
Hamm, Germany
Boehringer Ingelheim Investigational Site 164
Hanover, Germany
Boehringer Ingelheim Investigational Site 165
Hanover, Germany
Boehringer Ingelheim Investigational Site 166
Hanover, Germany
Boehringer Ingelheim Investigational Site 167
Hanover, Germany
Boehringer Ingelheim Investigational Site 168
Hartha, Germany
Boehringer Ingelheim Investigational Site 169
Heidelberg, Germany
Boehringer Ingelheim Investigational Site 170
Heidelberg, Germany
Boehringer Ingelheim Investigational Site 171
Heidelberg, Germany
Boehringer Ingelheim Investigational Site 172
Heidelberg, Germany
Boehringer Ingelheim Investigational Site 173
Heilbronn, Germany
Boehringer Ingelheim Investigational Site 174
Heilbronn, Germany
Boehringer Ingelheim Investigational Site 175
Hemmingen, Germany
Boehringer Ingelheim Investigational Site 176
Hemmingen, Germany
Boehringer Ingelheim Investigational Site 177
Herne, Germany
Boehringer Ingelheim Investigational Site 178
Hettstedt, Germany
Boehringer Ingelheim Investigational Site 179
Hilden, Germany
Boehringer Ingelheim Investigational Site 180
Husum, Germany
Boehringer Ingelheim Investigational Site 181
Itzehoe, Germany
Boehringer Ingelheim Investigational Site 182
Itzehoe, Germany
Boehringer Ingelheim Investigational Site 183
Kaiserslautern, Germany
Boehringer Ingelheim Investigational Site 184
Kaiserslautern, Germany
Boehringer Ingelheim Investigational Site 185
Kamen, Germany
Boehringer Ingelheim Investigational Site 186
Karlsruhe, Germany
Boehringer Ingelheim Investigational Site 187
Karlsruhe, Germany
Boehringer Ingelheim Investigational Site 188
Kempten, Germany
Boehringer Ingelheim Investigational Site 189
Kiel, Germany
Boehringer Ingelheim Investigational Site 190
Kiel, Germany
Boehringer Ingelheim Investigational Site 191
Kiel, Germany
Boehringer Ingelheim Investigational Site 192
Kirchheim, Germany
Boehringer Ingelheim Investigational Site 193
Koblenz, Germany
Boehringer Ingelheim Investigational Site 194
Koblenz, Germany
Boehringer Ingelheim Investigational Site 195
Koblenz, Germany
Boehringer Ingelheim Investigational Site 196
Koblenz, Germany
Boehringer Ingelheim Investigational Site 197
Konstanz, Germany
Boehringer Ingelheim Investigational Site 203
Königs Wusterhausen, Germany
Boehringer Ingelheim Investigational Site 204
Köthen, Germany
Boehringer Ingelheim Investigational Site 198
Krefeld, Germany
Boehringer Ingelheim Investigational Site 199
Krefeld, Germany
Boehringer Ingelheim Investigational Site 205
Landshut, Germany
Boehringer Ingelheim Investigational Site 206
Langen, Germany
Boehringer Ingelheim Investigational Site 207
Langenfeld, Germany
Boehringer Ingelheim Investigational Site 208
Langenfeld, Germany
Boehringer Ingelheim Investigational Site 209
Leipzig, Germany
Boehringer Ingelheim Investigational Site 210
Leipzig, Germany
Boehringer Ingelheim Investigational Site 211
Leipzig, Germany
Boehringer Ingelheim Investigational Site 212
Leonberg, Germany
Boehringer Ingelheim Investigational Site 213
Leverkusen, Germany
Boehringer Ingelheim Investigational Site 214
Leverkusen, Germany
Boehringer Ingelheim Investigational Site 215
Lichtenfels, Germany
Boehringer Ingelheim Investigational Site 216
Limburg, Germany
Boehringer Ingelheim Investigational Site 217
Lippstadt, Germany
Boehringer Ingelheim Investigational Site 221
Loerrach, Germany
Boehringer Ingelheim Investigational Site 218
Ludwigshafen, Germany
Boehringer Ingelheim Investigational Site 219
Ludwigshafen, Germany
Boehringer Ingelheim Investigational Site 222
Lüneburg, Germany
Boehringer Ingelheim Investigational Site 223
Lüneburg, Germany
Boehringer Ingelheim Investigational Site 224
Lützen, Germany
Boehringer Ingelheim Investigational Site 225
Magdeburg, Germany
Boehringer Ingelheim Investigational Site 226
Magdeburg, Germany
Boehringer Ingelheim Investigational Site 227
Mainz, Germany
Boehringer Ingelheim Investigational Site 228
Mainz, Germany
Boehringer Ingelheim Investigational Site 229
Mannheim, Germany
Boehringer Ingelheim Investigational Site 230
Mannheim, Germany
Boehringer Ingelheim Investigational Site 231
Marburg, Germany
Boehringer Ingelheim Investigational Site 232
Markkleeberg, Germany
Boehringer Ingelheim Investigational Site 233
Marktredwitz, Germany
Boehringer Ingelheim Investigational Site 234
Menden, Germany
Boehringer Ingelheim Investigational Site 235
Minden, Germany
Boehringer Ingelheim Investigational Site 236
Minden, Germany
Boehringer Ingelheim Investigational Site 237
Mönchengladbach, Germany
Boehringer Ingelheim Investigational Site 238
Mönchengladbach, Germany
Boehringer Ingelheim Investigational Site 239
Mönchengladbach, Germany
Boehringer Ingelheim Investigational Site 240
Mühlhausen, Germany
Boehringer Ingelheim Investigational Site 241
München, Germany
Boehringer Ingelheim Investigational Site 242
München, Germany
Boehringer Ingelheim Investigational Site 243
München, Germany
Boehringer Ingelheim Investigational Site 244
München, Germany
Boehringer Ingelheim Investigational Site 245
München, Germany
Boehringer Ingelheim Investigational Site 246
München, Germany
Boehringer Ingelheim Investigational Site 247
München, Germany
Boehringer Ingelheim Investigational Site 248
München, Germany
Boehringer Ingelheim Investigational Site 249
Münster, Germany
Boehringer Ingelheim Investigational Site 250
Münster, Germany
Boehringer Ingelheim Investigational Site 251
Münster, Germany
Boehringer Ingelheim Investigational Site 252
Neu-Ulm, Germany
Boehringer Ingelheim Investigational Site 253
Neumarkt, Germany
Boehringer Ingelheim Investigational Site 254
Neuwied, Germany
Boehringer Ingelheim Investigational Site 255
Niesky, Germany
Boehringer Ingelheim Investigational Site 256
Norderstedt, Germany
Boehringer Ingelheim Investigational Site 257
Norderstedt, Germany
Boehringer Ingelheim Investigational Site 258
Nordhausen, Germany
Boehringer Ingelheim Investigational Site 259
Nuremberg, Germany
Boehringer Ingelheim Investigational Site 260
Nuremberg, Germany
Boehringer Ingelheim Investigational Site 261
Nuremberg, Germany
Boehringer Ingelheim Investigational Site 262
Nuremberg, Germany
Boehringer Ingelheim Investigational Site 263
Oberursel, Germany
Boehringer Ingelheim Investigational Site 264
Offenburg, Germany
Boehringer Ingelheim Investigational Site 265
Olpe, Germany
Boehringer Ingelheim Investigational Site 266
Oranienburg, Germany
Boehringer Ingelheim Investigational Site 267
Oschatz, Germany
Boehringer Ingelheim Investigational Site 268
Oschersleben, Germany
Boehringer Ingelheim Investigational Site 269
Osnabrück, Germany
Boehringer Ingelheim Investigational Site 270
Parsberg, Germany
Boehringer Ingelheim Investigational Site 271
Peine, Germany
Boehringer Ingelheim Investigational Site 272
Pforzheim, Germany
Boehringer Ingelheim Investigational Site 273
Plauen, Germany
Boehringer Ingelheim Investigational Site 274
Plauen, Germany
Boehringer Ingelheim Investigational Site 275
Plauen, Germany
Boehringer Ingelheim Investigational Site 276
Potsdam, Germany
Boehringer Ingelheim Investigational Site 277
Pulheim, Germany
Boehringer Ingelheim Investigational Site 278
Rathenow, Germany
Boehringer Ingelheim Investigational Site 279
Ratingen, Germany
Boehringer Ingelheim Investigational Site 280
Raubach, Germany
Boehringer Ingelheim Investigational Site 281
Regensburg, Germany
Boehringer Ingelheim Investigational Site 282
Remscheid, Germany
Boehringer Ingelheim Investigational Site 283
Remscheid, Germany
Boehringer Ingelheim Investigational Site 284
Rostock, Germany
Boehringer Ingelheim Investigational Site 285
Rostock, Germany
Boehringer Ingelheim Investigational Site 286
Roth, Germany
Boehringer Ingelheim Investigational Site 287
Rottach-Egern, Germany
Boehringer Ingelheim Investigational Site 288
Rüsselsheim am Main, Germany
Boehringer Ingelheim Investigational Site 289
Rüsselsheim am Main, Germany
Boehringer Ingelheim Investigational Site 290
Saalfeld, Germany
Boehringer Ingelheim Investigational Site 291
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site 292
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site 293
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site 294
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site 295
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site 296
Saarlouis, Germany
Boehringer Ingelheim Investigational Site 297
Saarlouis, Germany
Boehringer Ingelheim Investigational Site 314
Saint Ingbert, Germany
Boehringer Ingelheim Investigational Site 298
Salzgitter, Germany
Boehringer Ingelheim Investigational Site 299
Schmallenberg, Germany
Boehringer Ingelheim Investigational Site 300
Schmölln, Germany
Boehringer Ingelheim Investigational Site 301
Schmölln, Germany
Boehringer Ingelheim Investigational Site 302
Schwabach, Germany
Boehringer Ingelheim Investigational Site 303
Schwandorf in Bayern, Germany
Boehringer Ingelheim Investigational Site 305
Schwäbisch Gmünd, Germany
Boehringer Ingelheim Investigational Site 304
Schwedt, Germany
Boehringer Ingelheim Investigational Site 306
Sebnitz, Germany
Boehringer Ingelheim Investigational Site 307
Seevetal, Germany
Boehringer Ingelheim Investigational Site 308
Siegen, Germany
Boehringer Ingelheim Investigational Site 309
Simmern, Germany
Boehringer Ingelheim Investigational Site 310
Sinsheim, Germany
Boehringer Ingelheim Investigational Site 311
Solingen, Germany
Boehringer Ingelheim Investigational Site 312
Sondershausen, Germany
Boehringer Ingelheim Investigational Site 313
Sonneberg, Germany
Boehringer Ingelheim Investigational Site 315
Stade, Germany
Boehringer Ingelheim Investigational Site 316
Stadthagen, Germany
Boehringer Ingelheim Investigational Site 317
Starnberg, Germany
Boehringer Ingelheim Investigational Site 318
Starnberg, Germany
Boehringer Ingelheim Investigational Site 319
Staufen, Germany
Boehringer Ingelheim Investigational Site 320
Steinbach, Germany
Boehringer Ingelheim Investigational Site 321
Steinhagen, Germany
Boehringer Ingelheim Investigational Site 322
Steinhagen, Germany
Boehringer Ingelheim Investigational Site 323
Strausberg, Germany
Boehringer Ingelheim Investigational Site 324
Straußfurt, Germany
Boehringer Ingelheim Investigational Site 325
Stuttgart, Germany
Boehringer Ingelheim Investigational Site 326
Stuttgart, Germany
Boehringer Ingelheim Investigational Site 327
Stuttgart, Germany
Boehringer Ingelheim Investigational Site 328
Stuttgart, Germany
Boehringer Ingelheim Investigational Site 329
Teltow, Germany
Boehringer Ingelheim Investigational Site 330
Teterow, Germany
Boehringer Ingelheim Investigational Site 331
Teuchern, Germany
Boehringer Ingelheim Investigational Site 332
Troisdorf, Germany
Boehringer Ingelheim Investigational Site 333
Ulm, Germany
Boehringer Ingelheim Investigational Site 334
Uttenreuth, Germany
Boehringer Ingelheim Investigational Site 335
Waiblingen, Germany
Boehringer Ingelheim Investigational Site 336
Waren, Germany
Boehringer Ingelheim Investigational Site 337
Weilheim, Germany
Boehringer Ingelheim Investigational Site 338
Weyhe, Germany
Boehringer Ingelheim Investigational Site 339
Wiesbaden, Germany
Boehringer Ingelheim Investigational Site 340
Wiesbaden, Germany
Boehringer Ingelheim Investigational Site 341
Wiesloch, Germany
Boehringer Ingelheim Investigational Site 342
Wilhelmshaven, Germany
Boehringer Ingelheim Investigational Site 343
Wilhelmshaven, Germany
Boehringer Ingelheim Investigational Site 344
Wilhelmshaven, Germany
Boehringer Ingelheim Investigational Site 345
Witten, Germany
Boehringer Ingelheim Investigational Site 346
Witten, Germany
Boehringer Ingelheim Investigational Site 347
Witten, Germany
Boehringer Ingelheim Investigational Site 220
Wittenberg, Germany
Boehringer Ingelheim Investigational Site 348
Wolfsburg, Germany
Boehringer Ingelheim Investigational Site 349
Wolfsburg, Germany
Boehringer Ingelheim Investigational Site 350
Würzburg, Germany
Boehringer Ingelheim Investigational Site 351
Zerbst, Germany
Boehringer Ingelheim Investigational Site 352
Zirndorf, Germany
Related Publications (2)
Rau-Berger H, Kroker A, Mitfessel H, Schmidt H, Glaab T Assessment of COPD-therapy with tiotropium by the treating pneumologist. 53rd Cong of the German Respiratory Society, Nuremberg, 29 Mar - 1 Apr 2012 (Poster), (2012)
BACKGROUNDGlaab T, Kroker A, Mitfessel H, Schmdit H, Rau-Berger H Evaluation of COPD treatment success by office-based pneumologists using the example of tiotropium. 21st Ann Cong of the European Respiratory Society (ERS), Amsterdam, 24 - 28 Sep 2011 (Poster), (2011)
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Boehringer Ingelheim Call Center
- Organization
- Boehringer Ingelheim Pharmaceuticals
Study Officials
- STUDY CHAIR
Boehringer Ingelheim
Boehringer Ingelheim
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 18, 2009
First Posted
December 21, 2009
Study Start
January 1, 2010
Primary Completion
August 1, 2010
Last Updated
March 27, 2014
Results First Posted
March 22, 2012
Record last verified: 2014-02